📰 Analyst Vosser News
Analyst Vosser News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Analyst Vosser. Real-time updates on events, politics, business and more.
January 8, 2024
Bayer believes it is on course for possible approval following positive study data on the active substance elinzanetant for the treatment of certain menopausal symptoms. This non-hormonal treatment...
January 8, 2024
Bayer believes it is on course for a possible approval following positive study data on the active substance elinzanetant for the treatment of certain menopausal symptoms. This non-hormonal treatment...